98080-5

LOINC 2.82

SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection

SARS-CoV-2+SARSr-CoV RNA pnl Sal NAA+prb

Component

  • SARS coronavirus 2 & SARS-related coronavirus RNA panel

Specimen / system

  • Saliva

Class

  • PANEL.MICRO

Property

  • -

Scale

  • -

Method

  • Probe.amp.tar

Related names

  • 2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2+SARSr-CoV; SARS-CoV-2+SARSr-CoV RNA; SARS-CoV-2+SARSr-CoV RNA pnl; SARSr-CoV; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus

Index terms

  • 2019 Novel Coronavirus
  • 2019-nCoV
  • 3 Self-Sustaining Sequence Replication
  • 3SR SR
  • Amplif
  • Amplification
  • Amplified
  • Corona virus
  • COVID-19
  • COVID19
  • DNA NUCLEIC ACID PROBE
  • DNA probe
  • ID
  • II
  • Infectious Disease
  • InfectiousDisease
  • LAT
  • LCR
  • Ligase chain reaction
  • Ligation-activated transcription
  • Microbiology
  • NAA+probe
  • NAAT
  • NASBA
  • Nucleic acid sequence based analysis
  • Oral fluid
  • Pan
  • PANEL.MICROBIOLOGY
  • Panl
  • PCR
  • PH
  • Pnl
  • Point in time
  • Polymerase chain reaction
  • Probe amp
  • Probe with ampification
  • Probe with target amplification
  • Public Health
  • PublicHealth
  • QBR

19 further terms